Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NICE Ltd (NICE) vs Teladoc Health Inc (TDOC) Price & Performance

Teladoc Health IncTrade

Price performance (Past 24H)

Key statistics

NICE Ltd vs Teladoc Health Inc — how do they compare? NICE Ltd trades at $117 (market cap $6.83B), while Teladoc Health Inc trades at $5.54 (market cap $1.01B). The key difference: NICE Ltd is far larger — about 6.8× Teladoc Health Inc's market cap, and NICE Ltd is trading nearer its 52-week high, Teladoc Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NICE Ltd for 15 Days and Teladoc Health Inc for 39 Days on average.

NICETDOC
Market Cap
$6.83B$1.01B
Volume
444,6103,622,440
Sector
TechnologyHealth
52-Week High
$137.68$9.72
52-Week Low
$83.15$4.47
Typical Hold Time
15 Days39 Days
Enterprise Value
$6.57B$1.27B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

NICE Ltd

NICE (NICE) trades at $116.42, up 0.95% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $124.20. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $2.95 billion in 2025, though net income is projected to decline in 2026. Recent news highlights leadership in AI-driven contact center platforms and positive institutional buying interest.

The outlook for NICE is positive, supported by AI revenue growth and a reasonable valuation, but investors face risks from margin compression and earnings volatility. The stock's proximity to resistance at $118 suggests near-term consolidation may occur before further upside.

Teladoc Health Inc

Teladoc Health (TDOC) trades at $5.54, down 3.99% in the latest session, reflecting ongoing investor concerns despite recent earnings beats. The stock shows bearish technical signals with oversold conditions while fundamentals reveal a mixed picture - strong gross margins of 68.97% but persistent net losses. Recent management changes and legal investigations add uncertainty, though the company maintains solid cash flow from operations of $294.36 million.

TDOC presents a high-risk opportunity with significant upside potential given the $8.83 consensus price target, representing 59% upside. However, continued net losses, negative cash flow trends, and competitive pressures in telehealth create substantial execution risk. The stock's current valuation at 0.4x sales appears attractive if the company can achieve profitability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NICE
0% Buy100% Sell
Avg holding period · 15 Days
TDOC

No sentiment data available yet.

About NICE Ltd

NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.

Read more on NICE →

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC →